IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
33.19
+0.16 (0.48%)
At close: Mar 6, 2026, 4:00 PM EST
33.85
+0.66 (1.99%)
After-hours: Mar 6, 2026, 7:36 PM EST
IDEAYA Biosciences Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$51.21
Upside
+54.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $64 → $65 | Strong Buy | Maintains | $64 → $65 | +95.84% | Feb 19, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $49 | Buy | Reiterates | $49 | +47.63% | Feb 18, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +50.65% | Feb 18, 2026 |
| Wedbush | Wedbush | Buy Maintains $49 → $52 | Buy | Maintains | $49 → $52 | +56.67% | Feb 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $41 → $45 | Buy | Maintains | $41 → $45 | +35.58% | Jan 21, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +50.65% | Jan 7, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $59 → $60 | Strong Buy | Maintains | $59 → $60 | +80.78% | Jan 6, 2026 |
| Truist Securities | Truist Securities | Strong Buy Initiates $59 | Strong Buy | Initiates | $59 | +77.76% | Nov 24, 2025 |
| Mizuho | Mizuho | Buy Maintains $44 → $46 | Buy | Maintains | $44 → $46 | +38.60% | Nov 11, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $74 → $79 | Buy | Maintains | $74 → $79 | +138.02% | Oct 23, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $27 → $30 | Hold | Maintains | $27 → $30 | -9.61% | Oct 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $38 → $41 | Buy | Maintains | $38 → $41 | +23.53% | Oct 21, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $62 | Strong Buy | Reiterates | $62 | +86.80% | Oct 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +50.65% | Sep 18, 2025 |
| Mizuho | Mizuho | Buy Maintains $43 → $44 | Buy | Maintains | $43 → $44 | +32.57% | Sep 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $36 → $38 | Buy | Maintains | $36 → $38 | +14.49% | Sep 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.